The genetic variant rs72613567:TA in the gene HSD17B13, associated with a reduced risk of MASH and fibrosis, encodes an uncharacterized member of the hydroxysteroid 17-beta dehydrogenase family. This evidence concerns the gene HSD17B13 and metabolic dysfunction-associated steatohepatitis.